MB
Moleculin Biotech, Inc.
MBRX · NASDAQ
$0.71 +2.88% (+$0.02)
1M +84.39%
Market Cap $3.68M
P/E Ratio -
Div. Yield -
ROE 816.56%
Bulios Fair Price
$0.89
25.4% upside
Trenutna cena
$0.71
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MBRX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.32x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 34.00%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 242.25%
Asset turnover 0.00x
ROE 816.56%
Debt
54 /100
Moderate Debt/Equity 0.03x
Int. coverage -387.91x
Current ratio 0.94x
Stability
24 /100
Unstable Beta 1.83x
Profitable years 0
EPS volatility 41.63%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MBRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Walter V. Klemp
Employees
17
Headquarters
Houston
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report